These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30111588)

  • 1. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload.
    Zoccali C; Mallamaci F
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1432-1434. PubMed ID: 30111588
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium Intake and Chronic Kidney Disease.
    Borrelli S; Provenzano M; Gagliardi I; Michael A; Liberti ME; De Nicola L; Conte G; Garofalo C; Andreucci M
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and management of fluid overload in children on dialysis.
    Hayes W; Paglialonga F
    Pediatr Nephrol; 2019 Feb; 34(2):233-242. PubMed ID: 29523958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: A Focus on Heart Failure.
    Bansal N
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1426-1428. PubMed ID: 30111585
    [No Abstract]   [Full Text] [Related]  

  • 5. How to successfully achieve salt restriction in dialysis patients? What are the outcomes?
    Ok E
    Blood Purif; 2010; 29(2):102-4. PubMed ID: 20093812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension, left ventricular hypertrophy and heart failure].
    Mancia G; Giannattasio C; Grassi G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():5S-8S. PubMed ID: 8117522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.
    Dubin RF; Deo R; Bansal N; Anderson AH; Yang P; Go AS; Keane M; Townsend R; Porter A; Budoff M; Malik S; He J; Rahman M; Wright J; Cappola T; Kallem R; Roy J; Sha D; Shlipak MG;
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):60-68. PubMed ID: 28062676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition in cardiovascular disease: salt in hypertension and heart failure.
    He FJ; Burnier M; Macgregor GA
    Eur Heart J; 2011 Dec; 32(24):3073-80. PubMed ID: 21705359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
    Heart Vessels; 2020 Oct; 35(10):1446-1453. PubMed ID: 32430700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hypertension and cardiovascular disorder in children with chronic kidney disease.
    Peco-Antić A; Paripović D
    Srp Arh Celok Lek; 2014; 142(1-2):113-7. PubMed ID: 24684043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt and hypertension in end-stage renal disease.
    Kooman JP; Leunissen KM; Luik AJ
    Blood Purif; 1998; 16(6):301-11. PubMed ID: 10343076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, left ventricular hypertrophy and chronic kidney disease.
    Taddei S; Nami R; Bruno RM; Quatrini I; Nuti R
    Heart Fail Rev; 2011 Nov; 16(6):615-20. PubMed ID: 21116711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Vrtovsnik F; Fartoux L
    Nephrol Ther; 2016 Dec; 12(7S):S10-S11. PubMed ID: 28132669
    [No Abstract]   [Full Text] [Related]  

  • 16. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
    Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial stiffness in arterial hypertension. A new risk factor for left ventricular hypertrophy and cardiac insufficiency?].
    Baulmann J; Homsi R; Un S; Vetter H; Düsing R; Mengden T
    Dtsch Med Wochenschr; 2004 Feb; 129(9):447-52. PubMed ID: 14970918
    [No Abstract]   [Full Text] [Related]  

  • 20. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.